← Back to All Filings
Vertex Pharmaceuticals Executive Granted 8,682 Restricted Stock Units
VERTEX PHARMACEUTICALS INC / MA
$VRTX4CIK: 0000875320
Subscribe to track VRTX
Premium users can add ticker alerts and receive realtime notification updates.
Filing Summary
Form 4 Alert: VERTEX PHARMACEUTICALS INC / MA ($VRTX) Insider: Jasper van Grunsven (EVP, CP and NPPO) Type: Grant/Award (Code A) Shares: 8,682 @ $0.00 Shares Held Post-Transaction: 8,682 Filing Date: 2026-09-10
Comprehensive Analysis
Insider Grant Analysis
- Issuer: Vertex Pharmaceuticals Inc / MA (NASDAQ:
VRTX) - Insider: Jasper van Grunsven, EVP, CP and NPPO
- Transaction Details: On September 8, 2026, Jasper van Grunsven received an equity grant of 8,682 restricted stock units (RSUs) of Common Stock at $0 per share.
- Vesting Schedule: The restricted stock unit award vests in installments beginning on September 8, 2027.
- Post-Transaction Holdings: Direct beneficial ownership increased to 8,682 shares.
- Market Significance: Low. This is a routine executive equity compensation award and does not reflect open-market discretionary trading activity.
Get Real-Time Alerts
Join our community to receive instant notifications when high-significance filings are published
Important Disclaimer
This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.
Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.